Volume 17 Issue 9
Aug.  2022
Turn off MathJax
Article Contents
ZHANG Hui, ZHANG Shao-wei, YU De-hua, LU Yuan. Research progress on drug therapy of mild cognitive impairment[J]. Chinese Journal of General Practice, 2019, 17(9): 1571-1574,1591. doi: 10.16766/j.cnki.issn.1674-4152.001000
Citation: ZHANG Hui, ZHANG Shao-wei, YU De-hua, LU Yuan. Research progress on drug therapy of mild cognitive impairment[J]. Chinese Journal of General Practice, 2019, 17(9): 1571-1574,1591. doi: 10.16766/j.cnki.issn.1674-4152.001000

Research progress on drug therapy of mild cognitive impairment

doi: 10.16766/j.cnki.issn.1674-4152.001000
  • Received Date: 2018-11-12
    Available Online: 2022-08-05
  • Mild cognitive impairment(MCI) is now a common condition in older people. It's a clinical condition between normal aging and mild dementia. Therefore, early intervention for mild cognitive impairment to improve cognitive decline and delay its transition to dementia is particularly important. In recent years, people around the world have been exploring ways to better prevent and treat MCI through drug and nutrient intervention, physical exercise, life behavior intervention and cognitive training. Whether those drugs and nutrients that can prevent and control the risk factors of mild cognitive impairment can be used in the prevention stage of MCI is worthy of attention and needs further research and confirmation. This paper will expound the research on the treatment of mild cognitive impairment drugs and nutrients in recent years, providing a basis for further exploring the drug treatment of mild cognitive impairment.

     

  • loading
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (697) PDF downloads(3) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return